MORGAN STANLEY

Holdings History for NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

Symbol: NPCE on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 2,489,391 shares
Security Ownership %: 8.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in NeuroPace Inc Common Stock, par value $0.001 per share (NPCE)

04 Feb 2025 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,489,391 shares of NeuroPace Inc Common Stock, par value $0.001 per share (NPCE). This represents 8.3% ownership of the company. This is the first filing by MORGAN STANLEY disclosing ownership of NeuroPace Inc Common Stock, par value $0.001 per share (NPCE).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Morgan Stanley	8.3%		$30,619,509	2,489,391			$12.30	13G/A	31 Dec 2024	04 Feb 2025, 12:50

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	0%	-0%	$26,251,405	2,546,208	-38,865	-1.5%	$10.31	Q3 2025
30 Jun 2025	0%	+0%	$28,797,713	2,585,073	+54,453	+2.2%	$11.14	Q2 2025
31 Mar 2025	0%	+0%	$31,101,321	2,530,620	+38,790		$12.29	Q1 2025
31 Dec 2024	0%	-0%	$27,883,578	2,491,830	-2,511		$11.19	Q4 2024
30 Sep 2024	0%	+0%	$17,385,557	2,494,341	+23,199		$6.97	Q3 2024
30 Jun 2024	0%	-0%	$18,681,834	2,471,142	-12,841		$7.56	Q2 2024
31 Mar 2024	0%	0%	$32,788,576	2,483,983	0		$13.20	Q1 2024
31 Dec 2023	0%	0%	$25,369,982	2,460,716	0		$10.31	Q4 2023
30 Sep 2023	0%	+0%	$23,349,237	2,399,716	+40,850	+1.7%	$9.73	Q3 2023
30 Jun 2023	0%	+0%	$10,591,308	2,358,866	+100,850	+4.5%	$4.49	Q2 2023
31 Mar 2023	0%	+0%	$10,477,194	2,258,016	+69,423	+3.2%	$4.64	Q1 2023
31 Dec 2022	0%	+0%	$3,261,004	2,188,593	+64,994	+3.1%	$1.49	Q4 2022
30 Sep 2022	0%	+0%	$7,963,000	2,123,599	+138,479	+7%	$3.75	Q3 2022
30 Jun 2022	0%	+0%	$9,826,000	1,985,120	+949,336	+92%	$4.95^*	Q2 2022
31 Mar 2022	0%	+0%	$8,504,000	1,035,784	+769,578	+289%	$8.21^*	Q1 2022
31 Dec 2021	0%	+0%	$2,684,000	266,206	+258,580	+3391%	$10.08^*	Q4 2021
30 Sep 2021	0%	0%	$121,000	7,626	+34	+0.45%	$15.87	Q3 2021
30 Jun 2021	0%	+0%	$181,000	7,592	+7,592	NEW	$23.84	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.